Introduction
============

CpG islands (CGIs) are clusters of CpG dinucleotides, which are mainly located at the 5′-end of a gene. Only a few CGIs are located in an intron. Most of the CGIs are unmethylated ([@evu125-B7]; [@evu125-B8]). Exceptions are alleles silenced by genomic imprinting or X inactivation as well as some tissue-specific genes. So far, nearly 100 imprinted genes have been identified in human and mouse. Although some of them are imprinted in all tissues, others are imprinted in specific tissues or at definite steps of development only ([@evu125-B1]).

Previous studies have shown that imprinting of the human *RB1* gene is due to the presence of a differentially methylated CGI (CpG85) in intron 2, which is part of a retrocopy derived from the *PPP1R26* gene on chromosome 9 ([@evu125-B9], [@evu125-B10]; [@evu125-B24]). Retrotransposition describes the process of the integration of a reverse-transcribed mRNA into another genomic location. [@evu125-B19] confirmed allelic methylation of the intronic *RB1* CGI by screening of reciprocal genome-wide uniparental disomies using the Illumina Infinium methylation27 BeadChip microarray. The murine *Rb1* gene does not have this retrocopy and is not imprinted. On the other hand, several imprinted genes in the mouse have arisen from retrotransposition ([@evu125-B27]; [@evu125-B5]; [@evu125-B28]).

In the last few years, several studies have taken a genome-wide look at DNA methylation and genomic imprinting. These studies include theoretical approaches (computational models for prediction) ([@evu125-B16]; [@evu125-B12]) as well as practical approaches using microarrays or deep-sequencing technologies ([@evu125-B15]). Recently, [@evu125-B4] identified 21 novel differentially methylated regions (DMRs), 15 of which are placental restricted. The authors characterized imprinted methylation in different tissues, defined methylation profiles at known imprinted domains and identified new imprinted DMRs ([@evu125-B4]).

Another focus of genomic imprinting studies is on evolution of imprinting and also the evolution of CGIs in different mammals. So far, the underlying molecular and evolutionary mechanisms of the arising of imprinting during mammalian evolution are poorly understood, but the acquisition of novel CGIs was a key genomic change for the evolution of imprinting ([@evu125-B25]).

In this study, we have investigated whether the *RB1*/*Rb1* locus is unique with respect to the above mentioned genetic and epigenetic differences between human and mouse. We have also determined the time points when retrocopy-associated intronic CGIs appeared during evolution. This was done by sequence comparisons, methylation analysis, and identification of evolutionary origins of all human and murine CGIs.

Materials and Methods
=====================

Whole-Genome Bisulfite Sequencing
---------------------------------

Human monocytes from two healthy male blood donors were obtained after written informed consent and anonymized (laboratory IDs M55900 and 43_Hm1_BIMo_Ct). Genome-wide methylation analysis was performed following the "Whole-Genome Bisulfite Sequencing for Methylation Analysis" protocol as released by Illumina. The generated data are referred to as methylome 1 and 2, respectively, and have been deposited with ENA (PRJEB5800) and EGA (EGAS00001000719).

Briefly, 4 µg of genomic DNA was fragmented by adaptive focused Acoustics on a Covaris S220 (Covaris Inc., Woburn, MA) for 80 s with a duty cycle of 10%, intensity of 5, and cycles per burst of 200. The DNA fragments are blunt-ended and phosphorylated, and a single "A" nucleotide is added to the 3′-ends using Paired-End Sample Preparation Kit (Illumina, San Diego, CA) following the manufacturer's protocol. Adapter ligation was performed following the protocol of the "Paired-End Sample Preparation Kit" (Paragraph: Ligate Adapters) with following modifications: 10 µl of TruSeq-methylated DNA adapter Index (TruSeq DNA Sample Preparation Kit v2, Illumina) instead of PE Adapter Oligo Mix was used. Adaptor-ligated DNA was isolated by two rounds of purification with AMPure XP beads (Beckman Coulter Genomics) and eluted in 22.5 µl resuspension buffer (RSB) buffer. Bisulfite conversion of 20 µl of library DNA was performed using EZ DNA Methylation-Gold Kit (Zymo Research, Irvine, CA) following the manufacturer's instructions. The bisulfite-modified library fragments were polymerase chain reaction (PCR) amplified in four separate tubes using HotStarTaq polymerase (Promega, Madison, WI, USA) under the following conditions: Initial denaturation (95 °C for 2 min); amplification (10 cycles 95 °C for 30 s, 60 °C for 30 s, and 72 °C for 30 s); and final extension (72 °C for 5 min).

Quality control of DNA libraries involved Agilent DNA HS chip analysis as well as the Qubit HS DNA assay. Libraries were denatured, diluted, and mixed with a PhiX library (2%) and subjected to clustering on paired-end flow cells as recommended by Illumina. Sequencing on the HiSeq2500 platform (Illumina) involved 101 cycles for read1, 7 cycles for the barcode read, and 101 cycles for read2. Bcl files were converted into fastq format using the configureBcltoFastq script in CASAVA1.8.2.

Whole-Genome Methylation Analysis
---------------------------------

Adapters of the paired-end reads were trimmed by cutadapt (parameter: Minimum length 30 bp, quality cutoff 20) ([@evu125-B17]) and afterwards the reads were mapped using methylCtools (default parameters, reference: hs37d5) implemented by Volker Hovestadt et al. (unpublished data). MethylCtools provides the functionality to map bisulfite-treated DNA with Burrows--Wheeler Alignment Tool (BWA) ([@evu125-B13]). SAMtools were used for sorting BAM files and coverage calculation by summing up the SAMtools mpilepup output ([@evu125-B14]). Duplicated reads were marked by PicardTools (<http://picard.sourceforge.net>, last accessed June 25, 2014), which also yields the mapping statistics. Finally, the methylation values were called, stored as BED files, and further transformed into BIGWIG files by bedGraphToBigWig (<http://genome.ucsc.edu/>, last accessed June 25, 2014). Single reads of potential DMRs were analyzed using the Integrative Genomic Viewer (IGV) Browser ([@evu125-B26]). For detailed analyses, statistics, and graphical output, the open source statistic software R was used (<http://www.r-project.org/>, last accessed June 25, 2014).

Data Collection
---------------

CGI sequence and information (excluding chromosome Y) tracks for human (CRCh37/hg19: *n* = 27,537 CGIs) and mouse (NCBI/mm10: 15,997 CGIs) were downloaded from the UCSC Genome Browser ([@evu125-B18]). All CGIs fulfill the criteria of a CGI from 1987 ([@evu125-B6]). For obtaining information on retrogenes, we also downloaded the retroposed genes track from the UCSC Browser.

Data from the Consensus CDS (CCDS) project were used to get detailed information about a set of human and mouse protein-coding regions (*n* = 14,990) in high quality which are available for both organisms ([@evu125-B22]). For additional information about transcription start and end, the HUGO Gene Nomenclature Committee website (<http://www.genenames.org/>, last accessed June 25, 2014) was utilized. In addition to the two methylome data sets, 18 published methylome data sets available under the accession number GSE46644 ([@evu125-B30]) were downloaded as BED files.

The collected information was merged and evaluated by using the Perl programming language (<http://www.perl.org/>, last accessed June 25, 2014).

CGI Location
------------

For our study, we serially numbered all CGIs from one organism with a unique ID (e.g., 134_1\_hg19 and 23_1\_mm10) and classified them with regard to CCDS location using Perl. A CGI is assigned to a CCDS if there is an overlap between CGI coordinates and the CCDS coordinates (200 bp in front of the transcription start site \[TSS\] to the transcription end). If a CGI maps to more than one CCDS, this CGI is listed as two or more CGIs, which is indicated by the number in front of the reference genome (e.g., the IDs 134_1\_hg19, 134_2\_hg19, and 134_3\_hg19 stand for the same CGI, but it can belong to three different CCDS). We have defined the following five classes to characterize the location of a CGI: TSS (200 bp region upstream of the TSS), 5′-UTR, CDS (Exon), CDS (Intron), and 3′-UTR where a CGI can belong to no class, one class, or more classes (see [supplementary fig. S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1) online).

Sequence Comparison
-------------------

For sequence comparison between human and murine sequences, we have performed pairwise alignments with the standalone program blast2seq (blast two sequences) ([@evu125-B29]). To analyze whether a CGI has sequence similarities to sequences elsewhere in the human genome the basic local alignment search tool (BLAST) is used ([@evu125-B2]). In this study, a discontiguous MEGA BLAST search with standard parameters against all assembled scaffolds of the human genome was done (Database Name: Genome \[all assemblies scaffolds\]; Description: *Homo sapiens* all assemblies \[GCF_000001405.22 GCF_000306695.1 GCF_000002135.2 GCF_000002125.1\] scaffolds in NCBI Annotation Release 104; Program: BLASTN 2.2.28) ([@evu125-B29]). This analysis is also necessary to assign a putative origin of a particular CGI.

BLAT Evolution Analysis
-----------------------

To determine the time points when CGIs appeared during evolution we have used BLAT, an online available tool on the UCSC Genome Browser website ([@evu125-B11]). BLAT searches with the human/nonmurine intronic CGIs and flanking exons have been performed in the following seven primate genomes: Chimpanzee (CSAC 2.1.4/panTro4), gorilla (gorGor3.1/gorGor3), orang-utan (WUGSC 2.0.2/ponAbe2), gibbon (GGSC Nleu3.0/nomLeu3), rhesus (BGI CR_1.0/rheMac3), marmoset (WUGSC3.2/calJac3), and bushbaby (Broad/otoGar3).

Genotyping
----------

Primers for genotyping *PDXDC1* (rs9928601)*, PARP11* (rs12319851), and *ASRGL1* (rs11231058) are listed in [supplementary table S4](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1) online. For the loci *PDXDC1* and *ASRGL1*, each 25 µl reaction contained 130 ng of genomic DNA, 0.4 µM of each primer, 80 µM of each dNTP (dATP, dCTP, and dTTP), 32 µM of dGTP, 48 µM of 7-deaza-2′-deoxy-guanosine-5′-triphosphate (Roche, Basel, Schweiz), 1.5 mM MgCl~2~, 0.5 M betaine (USB Corporation, Cleveland, OH, USA), 1× Green GoTaq Reaction Buffer, and 5 units GoTaq G2 DNA Polymerase (Promega). The PCR conditions for the loci *PDXDC1* and *ASRGL1* were as follows (for Tm = *X* see [supplementary table S4](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1) online): 95 °C for 2 min; 45 cycles of 96 °C for 30 s, *X*°C for 30 s, and 72 °C for 45 s; and 72 °C for 7 min.

For *PARP11*, each 25 µl reaction contained 100 ng of genomic DNA, 0.4 µM of each primer, 200 µM of each dNTP (dATP, dCTP, dTTP, and dGTP), 1.5 mM MgCl~2~, 1× Green GoTaq Reaction Buffer, and 1.25 units GoTaq G2 DNA Polymerase (Promega). The PCR conditions for the *PARP11* were as follows: 95 °C for 2 min; 35 cycles of 95 °C for 30 s, 64 °C for 30 s, and 72 °C for 45 s; and 72 °C for 5 min. The PCR products were purified by MultiScreen Filtration (Millipore, Billerica, MA). The sequence reactions were performed with Big Dye Terminators (BigDye Terminator v1.1 Cycle Sequencing Kit; Applied Biosystems, Foster City, CA) and the cycle sequencing procedure. Reaction products were analyzed with an ABI 3130*xl* Genetic Analyzer and Sequencing Analysis software (Applied Biosystems).

Deep Bisulfite Amplicon Sequencing
----------------------------------

Human monocytes from 22 healthy male blood donors were obtained after written informed consent and anonymized (laboratory IDs R1-R17, P1-P3, K1, and K2). After DNA extraction, bisulfite treatment was carried out using the EZ DNA Methylation-Gold Kit (Zymo Research Europe, Freiburg, Germany) according to the manufacturer's protocol. Generation of bisulfite amplicon libraries, sample preparation, and sequencing on the Roche 454 GS junior system were carried out as previously described ([@evu125-B3]). Primer sequences are given in [supplementary table S4](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1) online. For data analysis, we used the Python-based amplikyzer software developed in-house ([@evu125-B23]).

Results
=======

Finding Human Intronic CGIs Not Present in Mouse
------------------------------------------------

To compare CGIs from human and mouse, we first analyzed the location of the 27,537 human CGIs and 15,997 murine CGIs with regard to protein-coding regions as defined by the CCDS project (*n* = 14,990) ([table 1](#evu125-T1){ref-type="table"}). Only a subset of CGIs is located in exclusively intronic regions of a CCDS. Compared with the mouse genome, the human genome contains relatively more intronic CGIs (7.7% vs. 3.5%). We compared the sequences of the 2,174 human intronic CGIs with the sequences of the 579 murine intronic CGIs and found that there are 2,033 human intronic CGIs which are not present in mouse and analyzed these CGIs in more detail. In the following, we refer to these CGIs as human/nonmurine intronic CGIs. We have performed statistical analyses of these 2,033 CGIs, but their length, GC content, number of CpGs, and observed CpG/expected CpG ratio are not significantly different neither within this group nor to other CGI groups (data not shown). The mouse genome contains 470 intronic CGIs that are not present in the human genome, which will not be further analyzed in this study. Table 1Location of CGIs in the Human and Mouse Genomes with Regard to the CCDSCGIsHuman (hg19)Mouse (mm10)NumberPercentageNumberPercentageCGIs (UCSC)27,537---15,997---CGIs (analyzed)28,396[^a^](#evu125-TF2){ref-type="table-fn"}10016,643[^a^](#evu125-TF2){ref-type="table-fn"}100CGIs in gene17,80762.7112,58775.63CGIs not in gene1058937.294,05624.37TSS5031.774742.85TSS + 5′-UTR3,41212.023,02918.20TSS + 5′-UTR + CDS (Exon)1,0783.801,1897.14TSS + 5′-UTR + CDS (Exon) + CDS (Intron)5,22318.394,69228.19TSS + 5′-UTR + CDS (Exon) + CDS (Intron) + 3′-UTR2750.971070.645′-UTR4911.733031.825′-UTR + CDS (Exon)930.331120.675′-UTR + CDS (Exon) + CDS (Intron)2730.962251.355′-UTR + CDS (Exon) + CDS (Intron) + 3′-UTR270.10130.08CDS (Exon)8452.987814.69CDS (Exon) + CDS (Intron)2,4538.647584.55CDS (Exon) + CDS (Intron) + 3′-UTR6202.182221.33CDS (Exon) + 3′-UTR700.25390.23**CDS (Intron)2,1747.665793.48**3′-UTR2700.95640.38[^3][^4]

To find events similar to the retrotransposition of the *PPP1R26* gene into the *RB1* gene, we performed a MEGA BLAST search of the human genome with the sequences of the human/nonmurine intronic CGIs. This search found sequence similarities of 135 CGIs to one or more sequences elsewhere in the human genome. Of these, 31 CGIs have a very low sequence similarity to the additional hit (\<25 bp), are identical among each other or have only hits inside the source sequence. Most of the remaining 104 additional human hits (*n* = 76) overlap the TSS, the coding sequence (CDS), or both (TSS and CDS) of another gene. Only 13 CGIs show an additional hit in an intronic region and the hits of 15 CGIs are not located in or near a gene.

Of the 104 human/nonmurine intronic CGI with high sequence similarities elsewhere in the human genome, 45 overlap with an annotated retrogene (UCSC Genome Browser). This is only a small fraction of all retrocopy-associated CGIs in the human genome (*n* = 665). Of the 45 CGIs, 20 CGIs show at least two additional hits, all of which are associated with a retrogene. Most of the 59 CGIs that do not appear to be associated with an annotated retrogene have a related sequence on another chromosome (*n* = 43) or a long distance away. This suggests that they are associated with an unknown or a truncated retrogene rather than a duplicated gene.

Methylation Analysis of the Human/Nonmurine Intronic CGIs
---------------------------------------------------------

The methylation status of the 104 human/nonmurine intronic CGIs that show high sequence similarity to another human locus was analyzed in two monocyte methylome data sets methylome 1 and methylome 2 ([table 2](#evu125-T2){ref-type="table"} and [supplementary table S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1) online). Although most of the 104 CGIs are heavily methylated (77 CGIs have a methylation level over 80%) in the first methylome data set, 15 CGIs have a methylation level below 20% and 12 CGIs between 20% and 80%. Similar numbers were found in the second methylome data set ([table 2](#evu125-T2){ref-type="table"}). For further analysis, we selected those 14 CGIs that had a methylation level between 20% and 80% in at least one methylome data set. Nine out of these 14 CGIs had such a level in both methylomes, three only in methylome 1, and two only in methylome 2. Table 2Methylation Analysis of 104 Human/Nonmurine Intronic CGIsCGIsAll Analyzed CGIsMethylation (*m* \< 20%)Methylation (20% ≥ *m* ≤ 80%)Methylation (*m* \> 80%)Methylome 1    Numbers104151277    Methylation7725495    Coverage1481212Methylome 2    Numbers104181175    Methylation7746895    Coverage8589[^5]

For identification of allele-specific methylation, we first determined the methylation level of each sequence read of these CGIs ([table 3](#evu125-T3){ref-type="table"}, [fig. 1](#evu125-F1){ref-type="fig"}, and [supplementary table S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1) online). We expected that differentially methylated CGIs had mainly unmethylated (methylation \<20%) and methylated reads (methylation \>80%) and less than 20% partially methylated reads (methylation between 20% and 80%). To exclude CGIs having a high degree of methylation in one part and a low degree of methylation in another part ([fig. 1](#evu125-F1){ref-type="fig"}*B*), we checked the methylation status of each CpG in a CGI by calculating variance (see row VAR in [table 3](#evu125-T3){ref-type="table"}) and standard deviation (see row SD in [table 3](#evu125-T3){ref-type="table"}). The standard deviation shows how much variation from the average exists. Whereas a differentially methylated CGI is expected to have a methylation level around 50% for each CpG ([fig. 1](#evu125-F1){ref-type="fig"}*A*) and a low standard deviation, randomly methylated CGI can have fully methylated and fully unmethylated CpGs ([fig. 1](#evu125-F1){ref-type="fig"}*B* and *C*) and therefore a high standard deviation. F[ig]{.smallcaps}. 1.---Methylation patterns of three intronic CGIs. For each CGI, a histogram showing the distribution of reads with different levels of methylation as well as a bar plot showing the methylation levels of each CpG across all reads within the CGI is shown. Red indicates the percentage of methylated CpGs and blue the percentage of unmethylated CpGs. (*A*) CGI 14414_1\_hg19 (*ASRGL1*) is mainly covered by unmethylated and highly methylated reads. Each CpG has approximately 50% of methylation. These results indicate that this CGI might be differentially methylated. (*B*) The CGI, 19870_1\_hg19 (*SLC7A5*), also, is mainly covered by unmethylated and highly methylated reads, however, the CpGs do not have approximately 50% methylation; whereas the 5′-end of the CGI is nearly unmethylated, the 3′-end is highly methylated. This result indicates that this CGI is not differentially methylated. (*C*) CGI 9009_1\_hg19 (*MAD1L1*) does not show a bimodal distribution of methylation, and the methylation level of individuals CpGs is highly variable. This result indicates that this CGI is not differentially methylated. Table 3Read Analysis and CpG Methylation of CGIs with Intermediate Methylation Levels (Methylome 1)CGI_IDGeneChr.Length (bp)Mean Methylation (%)Mean CoverageNumber of ReadsReads Unmethylated (\<20% methylation)Reads Methylated (\>80% methylation)Reads Partially Methylated (≥20% and \<80% methylation)CpG Methylation(Number)(%)(Number)(%)(Number)(%)VARSD1911_1\_hg19*DCAF*121481187023486920290.010.114675_1\_hg19*GXYLT2*3326731910887706530280.020.124754_1\_hg19*SLC9C1*3463329663147152320300.090.299009_1\_hg19*MAD1L1*7210788242814588330.080.29**14414_1\_hg19*ASRGL1*1125255104017432153250.020.13**15205_1\_hg19*CACNA2D4*1212198412188741437638200.030.18**15224_1\_hg19*PARP11*126984211108534945421090.050.21**15290_1\_hg19*CD163L1*1262423141535737412755360.080.27**16634_1\_hg19*RB1*1312226313193693611660840.020.1319100_1\_hg19*PDXDC1*1667975111042221676415140.020.16**19870_1\_hg19*SLC7A5*162075815451738173811240.190.44**20632_1\_hg19*MYO1D*174662275438701120590.030.18**20636_1\_hg19*ASIC2*175065864449204520450.080.2925767_1\_hg19*HSF2BP*214037017932224505421230.100.32[^6]

Based on these criteria, nine CGIs with a high number of partially methylated reads were excluded from further analysis ([supplementary material S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1) online). The remaining five CGIs are associated with the following genes: *ASRGL1* (14414_1\_hg19), *PARP11* (15224_1\_hg19), *RB1* (16634_1\_hg19), *PDXDC1* (19100_1\_hg19), and *MYO1D* (20632_1\_hg19).

Next, we analyzed the methylation status of these CGIs in previously published methylome data sets ([table 4](#evu125-T4){ref-type="table"}). Apart from human sperm DNA, in which the five CGIs are almost unmethylated, intermediate levels of methylation were found in nearly all tissues, although there appear to be tissue-specific differences. Single reads are not available from these data sets. Table 4CGI Methylation Levels in Other TissuesSample_NameCell/Tissue14414_1\_hg1915224_1\_hg1916634_1\_hg1919100_1\_hg1920632_1\_hg19*(ASRGL1)(PARP11)(RB1)(PDXDC1)(MYO1D)*Meth. (%)Cov.Meth. (%)Cov.Meth. (%)Cov.Meth. (%)Cov.Meth. (%)Cov.Monocyte methylome 1[^a^](#evu125-TF6){ref-type="table-fn"}Monocyte5510421163137511227Monocyte methylome 2[^a^](#evu125-TF6){ref-type="table-fn"}Monocyte49946872879622Frontal_cortex_normal_1[^b^](#evu125-TF7){ref-type="table-fn"}Cortex8427533876482857433Frontal_cortex_normal_2[^b^](#evu125-TF7){ref-type="table-fn"}Cortex83206333763242341324Frontal_cortex_AD_1[^b^](#evu125-TF7){ref-type="table-fn"}Cortex89225230763839451433Frontal_cortex_AD_2[^b^](#evu125-TF7){ref-type="table-fn"}Cortex88366943765641401644IMR90[^b^](#evu125-TF7){ref-type="table-fn"}Lung, fetal, fibroblast56185313821953322511Colon_Primary_Normal[^b^](#evu125-TF7){ref-type="table-fn"}Colon52386742795944471223Human sperm[^b^](#evu125-TF7){ref-type="table-fn"}Sperm941557711616Adult liver replicate 1[^b^](#evu125-TF7){ref-type="table-fn"}Liver82618174717754501028Adult liver replicate 2[^b^](#evu125-TF7){ref-type="table-fn"}Liver56535245615747491138Hippocampus middle replicate 1[^b^](#evu125-TF7){ref-type="table-fn"}Hippocampus middle88626750776536551926Hippocampus middle replicate 2[^b^](#evu125-TF7){ref-type="table-fn"}Hippocampus middle87356939774830461626Fetal heart (119)[^b^](#evu125-TF7){ref-type="table-fn"}Fetal heart6439383758513453727Fetal thymus (1,238)[^b^](#evu125-TF7){ref-type="table-fn"}Fetal thymus65292943494234632236Fetal adrenal (1,244)[^b^](#evu125-TF7){ref-type="table-fn"}Fetal adrenal52333726672952441026Fetal muscle leg (1,243)[^b^](#evu125-TF7){ref-type="table-fn"}Fetal muscle leg5535284454383252529Fetal brain (515)[^b^](#evu125-TF7){ref-type="table-fn"}Fetal brain78224621513019341020[^7][^8][^9]

For finding out whether the intermediate methylation levels of the five human/nonmurine CGIs resulted from allele-specific methylation (as published previously for the *RB1* locus; [@evu125-B9]), we performed deep bisulfite amplicon sequencing on monocyte DNA samples from unrelated donors heterozygous for a single-nucleotide polymorphism (SNP) in these regions. We failed to establish an amplicon for the *MYO1D* locus, but could analyze *ASRGL1*, *PARP11*, and *PDXDC1*. Of 22 donors, 14 were heterozygous for an A/G SNP at the *ASRGL1* locus (rs11231058). Four of these individuals showed allelic methylation differences more than 10% ([fig. 2](#evu125-F2){ref-type="fig"} and [supplementary table S5.1--5.3](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1) online). In three of these individuals, the G allele was less methylated, whereas in one individual the A allele was less methylated, which might reflect random variation or a parent-of-origin effect. Eleven donors were heterozygous for an A/G SNP at the *PARP11* locus (rs12319851). In 10/11 cases, allelic methylation differences were less than 10%. Fourteen donors were heterozygous for an A/C SNP at the *PDXDC1* locus (rs9928601). Almost all individuals showed allelic methylation differences (mean 40%). In 13/14 cases, the C allele was less methylated. In one case, we had parental DNA samples and found the less methylated C allele to be of paternal origin (data not shown). F[ig]{.smallcaps}. 2.---Single molecule methylation analysis of the intronic *ASRGL1*, *PARP11*, and *PDXDC1* CGIs in heterozygous individuals. Three examples are shown. The amplicons cover only parts of the CGIs, and some include flanking CpGs. The left part of the figure shows all amplicon reads, whereas the right part shows the sequence reads sorted by SNP allele. (*A*) Methylation pattern of the *ASRGL1* CGI. The first two CpGs do not belong to the CGI. (*B*) Methylation pattern of the *PARP11* CGI. (*C*) Methylation pattern of the *PDXDC1* CGI. The last four CpGs not belong to the CGI.

Evolutionary Origin of Human/Nonmurine Intronic CGIs
----------------------------------------------------

By BLAT searches in seven primate genomes, using the human sequences of the human/nonmurine intronic CGI and flanking exons, we could narrow down the time points when 86 CGIs of the 104 CGIs appeared during evolution ([table 5](#evu125-T5){ref-type="table"}). Because of sequence gaps in several primate genomes, it was not possible to detect all evolutionary time points ([supplementary table S3](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1) online). Most of the human/nonmurine intronic CGIs (57%) are present in the analyzed members of the superfamily Hominoidea (human, chimpanzee, gorilla, orang-utan, and gibbon). Only seven of the human/nonmurine intronic CGIs are present in the bushbaby, which belongs to the suborder Strepsirrhini, whereas all other analyzed primates belong to the suborder Haplorrhini ([@evu125-B21]). Table 5Evolution Analysis of 86 Human/Nonmurine Intronic CGIsSuborderHaplorrhiniStrepsirrhiniParvorderCatarrhiniPlatyrrhiniSuperfamilyHominoideaCercopithecoideaOrganismHumanChimpanzeeGorillaOrang-utanGibbonRhesusMarmosetBushbabyNumber of CGIs867367595944297[^10]

The five CGIs with intermediate methylation levels appeared at different time points during evolution ([fig. 3](#evu125-F3){ref-type="fig"}). As described in previous studies, CGI 16634_1\_hg19 (CpG85) of the *RB1* gene is present in all analyzed members of Haplorrhini, but not in the bushbaby (suborder Strepsirrhini) ([@evu125-B10]). The intronic CGIs of the genes *ASRGL1* (14414_1\_hg19) and *PARP11* (15224_1\_hg19) are present in all analyzed members in the superfamily Hominoidea. CGI 19100_1\_hg19 (*PDXDC1*) exists only in the human genome and CGI 20632_1\_hg19 (*MYO1D*) in human and chimpanzee. F[ig]{.smallcaps}. 3.---Evolutionary origin of the five CGIs with intermediate methylation levels. The figure illustrates a simplified genealogy (distances are not scaled) of all analyzed primate genomes. The red arrows indicate the time point when the CGIs entered the germ line.

In addition to CGI 16634_1\_hg19 (*RB1*), we found three human/nonmurine intronic CGIs (14414_1\_hg19 (*ASRGL1*), 19100_1\_hg19 (*PDXDC1*), and 15224_1\_hg19 (*PARP11*)) which are part of a retrocopy ([fig. 4](#evu125-F4){ref-type="fig"}). CGI 14414_1\_hg19 (*ASRGL1*) is part of a retrocopy derived from the *RCC2* gene on chromosome 11, CGI 15224_1\_hg19 (*PARP11*) from the *OTUD4* gene on chromosome 4, and CGI 19100_1\_hg19 (*PDXDC1*) from the *KIAA2013* gene on chromosome 1. In contrast to CGI 16634_1\_hg19 (*RB1*), which shares sequence similarity with two small methylated CGIs within the open-reading frame in exon 4 of the ancestral gene, the CGIs 14414_1\_hg19 (*ASRGL1*), 19100_1\_hg19 (*PDXDC1*), and 15224_1\_hg19 (*PARP11*) share sequence similarity with unmethylated CGIs spanning the 5′-end of the ancestral genes. The additional hit of CGI 20632_1\_hg19 (*MYO1D*) is not located in a gene, but a CGI on the X chromosome. The methylation of this ancestral CGI in monocytes from two male individuals is about 40%. According to the "UCSC Retroposed Gene Track," only one of these retrocopies is strongly expressed (*retro-KIAA2013*). The other three retrocopies are weakly expressed (*retro-RCC2*, *retro-OTUD4*, and *retro-PPP1R26P1*). F[ig]{.smallcaps}. 4.---Structure of the introns containing CGIs with intermediate methylation levels. The figure shows the location of the intronic CGIs and their putative ancestral origin. (*A*) Intron 3 of the *ASRGL1* gene containing the CGI 14414_1\_hg19 and the *retro-RCC2*. (*B*) Intron 1 of the *PARP11* gene containing CGI 15224_1\_hg19 and the *retro-OTUD4*. (*C*) Intron 1 of the *PDXDC1* gene containing CGI 19100_1\_hg19 and *retro-KIAA2013*. (*D*) Intron 1 of the *MYOD1* gene with CGI 20632_1\_hg19 and the putative ancestral origin, a CGI on the X chromosome. (*E*) Intron 2 of the *RB1* gene containing the CGI 16634_1\_hg19 and *retro-PPP1R26P1*.

Discussion
==========

Most of the CGIs in vertebrate genomes span the 5′-end of genes and contain binding sites for transcription factors and the RNA polymerase. Much less is known about intronic CGIs. Intronic CGIs may modify expression of the host gene, harbor an alternative start site, belong to a gene that is located within an intron of the host gene, or may have no function at all. Likewise, little is known about the evolutionary origin of intronic CGIs. Certainly, several intronic CGIs such as CpG85 (16634_1\_hg19) within the human *RB1* gene are the product of retrotransposition. CpG85 has acquired differential DNA methylation, which is causally related to imprinted expression of *RB1*. The mouse *Rb1* locus does not contain this CGI and is not imprinted. In a genome-wide study, we have investigated whether the *RB1/Rb1* locus is unique with respect to these differences and when intronic CGIs not present in the mouse appeared during evolution. The reidentification of CpG85 in our study demonstrates the reliability of our approach.

By calculating the location of all human and murine CGIs to one consistent data set of protein-coding regions available for both organisms, we found a considerably higher percentage (more than two times) of intronic CGIs in human than in mouse ([table 1](#evu125-T1){ref-type="table"}). Thus, the human genome does not only contain more CGIs than the mouse, but the proportion of intronic CGIs is also higher. By comparing the intronic CGIs in the human and mouse genome, we found that there are at least 2,033 human intronic CGIs that are not present in the mouse and at least 470 mouse intronic CGIs that are not present in humans. This demonstrates that novel CGIs have appeared in both evolutionary lineages. There may be more such CGIs, because we only investigated genes present in both species and included in the CCDS gene set.

Of the 2,033 human/nonmurine intronic CGIs analyzed in this study, 104 CGIs have a high sequence similarity to other sequences in the genome and at least 50% are part of a retrocopy. Of these CGIs, the majority is also found in other Hominoidea ([table 5](#evu125-T5){ref-type="table"}). The portion of the CGIs present in other primates is roughly correlated with the evolutionary relatedness of these species. Interestingly, 13 of these CGIs are not present in the genome of the closely related chimpanzee, including CGI 19100_1\_hg19 (*PDXDC1*), which has investigated here in more detail (see below). The bushbaby genome has only seven of these CGIs, suggesting that most of the 104 CGIs appeared after the split between Haplorrhini and Strepsirrhini. This finding lends some support to the idea that they are part of the retrotranspositional explosion that occurred in Haplorrhini about 40--50 Ma before the split between Catarrhini and Platyrrhini ([@evu125-B20]).

Although the majority of CGIs are unmethylated, approximately 75% of the 104 human/nonmurine intronic CGIs are fully methylated. This suggests that these CGIs have been methylated by the host defense mechanism and possibly are without function. Only approximately 15% of the 104 CGIs are unmethylated, suggesting that they have kept their original function or have acquired a new function depending on their new genomic environment. Five CGIs, including CpG85 from the imprinted *RB1* gene (16634_1\_hg19), have intermediate methylation levels in human monocytes and other tissues ([fig. 1](#evu125-F1){ref-type="fig"} and [tables 2--4](#evu125-T2 evu125-T3 evu125-T4){ref-type="table"}). Among these CGIs, four appear to have arisen by insertion of a retrocopy ([fig. 4](#evu125-F4){ref-type="fig"}). Only CGI 20632_1\_hg19, located in intron 1 of the *MYO1D* gene, does not appear to be associated with a retrocopy, but is related to a CGI on the X chromosome. It is possible that there is a X-chromosomal gene which has not yet been annotated. Since these CGIs are not completely methylated, they may have acquired a novel function.

As shown for the *RB1* locus, CpG85 (16634_1\_hg19) shows imprinted DNA methylation ([@evu125-B9]). For analyzing allelic methylation patterns of the other four CGIs, we performed targeted deep bisulfite sequencing in monocytes from individuals who were heterozygous for a common SNP. Although the analysis of 20632_1\_hg19 (*MYO1D*) failed, we could rule out allelic methylation differences of 15224_1\_hg19 (*PARP11*) and demonstrate partial allelic methylation differences of 14414_1\_hg19 (*ASRGL1*) and 19100_1\_hg19 (*PDXDC1*). Allelic methylation differences at the *PDXDC1* locus were much stronger than at the *ASRGL1* locus, but not as strong as at the *RB1* locus. Furthermore, our data suggest that the observed allelic methylation differences at the first two loci may not be parent-of-origin-specific, but sequence specific ([fig. 2](#evu125-F2){ref-type="fig"} and [supplementary table S5.1--S5.3](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1) online).

For further clarification of this issue, we compared our data with that of [@evu125-B4], who have recently performed a genome-wide search for imprinted genes and described 21 novel different DMRs. Of these, 15 are placental specific and therefore could not be identified in our analysis, which is based on monocytes. The other six novel DMRs, which showed intermediate methylation in five different tissues (blood, brain, liver, muscle, and kidney), were also not found by our analysis. Four DMRs (*PPIEL*, *WDR27*, *HTR5A*, and *CXORF56*) are only CpG rich and are not CGIs. The remaining two DMRs are in fact intronic, but have not come up in our analysis, because one DMR has no additional hit in the human genome (*NHP2L1*) and the other DMR (*WRB*) is not located in an intron in our data sets. [@evu125-B4] have found imprinted methylation at the *RB1* locus, but no evidence for imprinted methylation of any of the other four CGIs investigated in our study. They did observe differential methylation of CGI 19100_1\_hg19 (*PDXDC1*), but excluded it as an imprinted DMR based on uniparental disomy data. As suggested by our data, the methylation level at this locus depends on the DNA sequence. Thus, the two studies, which have a different focus, complement each other.

In summary, we have found that the human genome does not only contain more CGIs than the mouse, but the proportion of intronic CGIs is also higher (7.7% versa 3.5%). At least 2,033 human intronic CGIs are not present in the mouse genome. Of these, 104 CGIs have sequence similarities elsewhere in the human genome, and at least 45 belong to a retrogene. Most of the human/nonmurine CGIs with sequence similarities elsewhere in the human genome are biallelically methylated (∼75%) or unmethylated (∼15%). Only a few CGIs, including the intronic *RB1* CGI, occur as methylated and unmethylated copies. In contrast to imprinted methylation of the intronic *RB1* CGI, methylation levels of the intronic *ASRGL1* and *PDXDC1* CGIs appear to be affected by the DNA sequence. Methylated and unmethylated copies of these CGIs as well as of the intronic *PARP11* CGI are found in different human tissues. Interestingly, the proportion of methylated and unmethylated copies appears to vary between tissues, even in the case of the intronic *RB1* CGI, which in certain adult cell types is biallelically methylated, as judged from methylation levels more than 70% in these tissues ([table 4](#evu125-T4){ref-type="table"}). This demonstrates that the epigenetic state of these CGIs is more plastic compared with that of other CGIs. Our study further strengthens the notion that the epigenetic fate of the retrotransposed DNA depends on its DNA sequence and selective forces at the integration site.

Supplementary Material
======================

[Supplementary material S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1) and [tables S1--S3](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1) are available at *Genome Biology and Evolution* online (<http://www.gbe.oxfordjournals.org/>).
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[^1]: **Associate editor:** Bill Martin

[^2]: **Data deposition:** This project (methylome 1) has been deposited at ENA under the accession PRJEB5800 and methylome 2 at EGA under the accession EGAS000001000719.

[^3]: N[ote]{.smallcaps}.---The table shows the distribution of human and mouse CGIs dependent on their CCDS location. In addition to the total number, the percentages are given. Five classes for CGI characterization are defined, where a CGI can overlap no, one, or more classes. The classes are: TSS (200-bp region upstream of the TSS), 5′-UTR, CDS (Exon), CDS (Intron), and 3′-UTR (see [supplementary fig. S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1) online).

[^4]: ^a^The analyzed number of CGIs is higher than the downloaded number from the UCSC browser, because one CGI can belong to more than one CCDS.

[^5]: N[ote]{.smallcaps}.---The table summarizes degree of methylation (%) and number of CGIs analyzed in two monocyte methylome data set (methylome 1: 1,929,952,791 reads, duplication rate 0.22, mapping efficiency 0.99, and conversion 0.994; methylome 2: 1,407,767,072 reads, duplication rate 0.15, mapping efficiency 0.98, and conversion 0.996). CGIs are divided into three classes, corresponding to their methylation level. Methylation less than 20% (unmethylated), methylation between 20% and 80% (candidates for differential methylation), and methylation more than 80% (methylated).

[^6]: N[ote]{.smallcaps}.---This table shows the results of the read methylation and CpG methylation analysis of 14 candidate CGIs of methylome 1 (for methylome 2, see [supplementary table S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu125/-/DC1) online). In addition to CGI_ID, gene, chromosome, length, mean methylation, mean coverage, and number of reads, the reads are divided into three classes: Unmethylated, methylated, and partially methylated. The last column shows the results of the CpG methylation analyses, variance (VAR), and standard derivation (SD) over all single CpGs were calculated. Bold: CGIs that might be differentially methylated (partially methylated reads ≤20% and VAR ≤0.05).

[^7]: N[ote]{.smallcaps}.---For each CGI, mean methylation (meth.) and mean coverage (cov.) are specified.

[^8]: ^a^Data published in this article.

[^9]: ^b^Data published by [@evu125-B30].

[^10]: N[ote]{.smallcaps}.---The table gives an overview about the 86 human/nonmurine intronic CGIs and their evolution. The number stand for the human/nonmurine intronic CGIs which are present in the analyzed organism. In addition, the superfamilies, parvorders, and suborders are specified.
